Most people have a sense of what PTSD is, or at least they think they do.
If you ask someone to describe post-traumatic stress disorder, they’ll usually picture something fairly specific. A veteran hears a loud noise and is suddenly transported back to combat. Someone wakes from a nightmare and cannot immediately separate the dream from reality. A survivor of an assault finds themselves reliving what happened through vivid flashbacks.
Those experiences are real, and for many people, they are defining features of PTSD. At the same time, they are not the only ways trauma can shape a person’s life. Some people experience obvious reminders of what happened. Others notice changes that are more difficult to connect back to a traumatic event. Sleep becomes lighter. Concentration takes more effort than it once did. Social situations feel more draining. A person begins avoiding certain places or situations without consciously deciding to.
Trauma does not arrive in a single form, and PTSD does not always present in a single form either. Two people can meet diagnostic criteria for the same condition and have very different experiences of it (American Psychiatric Association [APA], 2022). One person’s symptoms may center around nightmares and flashbacks. Another person’s symptoms may show up primarily through hypervigilance, irritability, avoidance, or a persistent sense that they can never fully relax.
When people think about trauma, they often picture a single event. An assault. A deployment. A serious accident. A natural disaster. For many people, that is exactly what happened. For others, the story is more difficult to summarize. The source of distress may not be one event but years spent in an environment that felt unpredictable, unsafe, or emotionally overwhelming. Some people grew up walking on eggshells around an explosive parent. Others experienced repeated bullying, chronic emotional abuse, medical trauma, community violence, discrimination, or relationships in which they never felt entirely secure. Trauma can emerge from a single moment, but it can also develop through repeated experiences that gradually teach the nervous system to remain on guard (Zoellner et al., 2025).
Part of what makes PTSD difficult to recognize is that many of its effects overlap with experiences people commonly attribute to other causes. Poor sleep is easy to blame on stress. Difficulty concentrating can be attributed to burnout. Irritability may be dismissed as having too much on your plate. When symptoms develop gradually, they often become part of the background of daily life. People adapt to them. They work around them. They build routines that accommodate them. Sometimes years pass before someone stops and wonders whether all of these seemingly unrelated difficulties might be connected.
By the time many people begin exploring that possibility, they are often less focused on the traumatic event itself than on the ways their life feels different now. They want to know why they feel constantly on edge. They want to understand why situations that once felt manageable seem to require so much energy. They wonder why rest never quite feels restorative or why they remain alert in environments that are objectively safe.
The encouraging news is that PTSD is one of the most extensively studied conditions in mental health. Researchers have spent decades trying to understand what happens after trauma, why some symptoms persist, and which PTSD treatment options consistently help people improve (Rothbaum & Watkins, 2025). While there is still much to learn, the field has reached a remarkable degree of agreement about what works.
Before discussing treatment options, it helps to understand what PTSD actually is and, perhaps just as importantly, what it is not.
What PTSD Symptoms Actually Look Like
Clinicians organize PTSD symptoms into four broad categories: intrusive symptoms, avoidance, changes in mood and thinking, and changes in arousal or reactivity (APA, 2022). These categories are useful diagnostically, but they do not always capture what the condition feels like from the inside.
Intrusive symptoms are often the easiest to recognize. Flashbacks, nightmares, and unwanted memories tend to receive the most attention because they can be vivid and distressing. Some people experience them frequently. Others experience them only occasionally. In both cases, the common thread is that the past continues inserting itself into the present in ways that feel involuntary.
Avoidance is often more subtle. Most people do not wake up one day and decide to avoid their trauma. The process tends to unfold gradually. Someone stops driving through a particular intersection. They avoid certain conversations. They decline invitations they once would have accepted. These choices often feel practical at first. Over time, they can begin limiting opportunities, relationships, and experiences in ways that are difficult to recognize while they are happening.
Changes in mood and thinking can be equally challenging. Some people describe feeling emotionally numb. Others report persistent guilt, shame, or difficulty experiencing joy. Many begin viewing themselves, other people, or the world differently than they did before the trauma occurred. Trust becomes harder. Safety feels less certain. Future plans become more difficult to imagine.
The final symptom cluster involves changes in arousal and reactivity. This is the “always on” feeling that many people describe. Sleep becomes difficult. Concentration suffers. Small noises feel startling. Irritability increases. Relaxation becomes surprisingly difficult, even in situations that are objectively safe (Sartor et al., 2023).
One of the more interesting developments in trauma research over the past several decades has been the growing recognition that PTSD is not primarily a disorder of memory. That idea can feel counterintuitive because memories occupy such a prominent place in conversations about trauma. Flashbacks, nightmares, and intrusive recollections are among the symptoms most people associate with PTSD. Yet memory alone does not explain what clinicians observe.
Most people remember painful experiences. They remember grief, fear, heartbreak, humiliation, and loss. Some memories remain vivid for decades without fundamentally altering the way a person experiences safety in the present. The question that increasingly interested researchers was not why certain memories persisted. The question was why certain experiences continued influencing a person’s expectations long after the original threat had passed.
The answer turned out to involve far more than memory. PTSD affects attention, perception, emotion, physiology, and the brain’s ability to make predictions about the future (Rothbaum & Watkins, 2025). Human beings are constantly generating expectations about what is likely to happen next. Most of this occurs outside conscious awareness. We predict how people will respond to us. We predict whether situations are safe. We predict what deserves our attention and what can safely be ignored.
Trauma can alter those predictions in ways that are both understandable and difficult to detect. Someone who has experienced betrayal may approach relationships differently. Someone who has survived a serious accident may become more attentive to potential hazards while driving. A person who spent years in an unpredictable environment may become highly skilled at detecting subtle changes in other people’s moods. What looks like anxiety from the outside may, in some cases, reflect an ability that was once genuinely useful. Many people learn to anticipate conflict, disappointment, criticism, or danger long before they consciously realize they are doing it.
The challenge is that lessons learned during periods of genuine danger do not always update automatically when circumstances change. A person may understand intellectually that they are safe while still finding themselves reacting as though danger remains possible. They know the relationship ended years ago. They know the accident is over. They know they no longer live in the environment where the trauma occurred. Yet their body continues responding to reminders in ways that feel immediate and difficult to control.
Understanding that disconnect has shaped much of modern PTSD treatment. It has also helped explain why some interventions consistently produce better outcomes than others.
Why PTSD Treatment Often Starts With Therapy
One of the most important discoveries in trauma research emerged from a relatively simple observation. People often organize their lives around avoiding things that remind them of trauma.
This makes intuitive sense. If a particular place, conversation, memory, or situation consistently triggers distress, avoiding it can feel protective. Someone who was involved in a serious accident may choose a different route to work. A survivor of assault may avoid locations that remind them of what happened. A person who grew up in a chaotic environment may withdraw from conflict whenever possible because conflict has historically carried consequences that feel unpredictable or unsafe.
None of these choices are irrational. In many cases, they reduce distress in the short term. Anxiety decreases. Discomfort fades. Attention shifts elsewhere. The challenge is that the brain pays attention to outcomes. When avoidance consistently reduces distress, it can reinforce the idea that avoidance was necessary in the first place. The feared situation remains untested. The anticipated danger is never reevaluated. No new information enters the system.
Researchers became increasingly interested in this pattern because it appeared repeatedly across different forms of trauma. The details varied from person to person, but the underlying process remained remarkably consistent. The people who improved were not necessarily the people who became best at avoiding distress. More often, improvement occurred when people developed new experiences with the things they feared (Steenkamp et al., 2015). That observation eventually helped shape many of the therapies that remain the gold standard for PTSD treatment today.
PTSD Therapies With the Strongest Evidence
One of the more encouraging findings in trauma research is that there is no single path to recovery. Different people respond to different approaches, and the field has gradually moved away from the idea that there is one correct way to process trauma. At the same time, several therapies have accumulated enough evidence that they are consistently recommended by major organizations such as the American Psychological Association (Zoellner et al., 2025), the Department of Veterans Affairs, and the Department of Defense (Schnurr et al., 2024).
Although these therapies differ in their techniques, they share a common goal. They help people develop new experiences with memories, emotions, situations, and beliefs that have become linked to danger. Rather than helping people forget what happened, they help the brain learn that what happened in the past does not necessarily predict what will happen now.
Prolonged Exposure (PE)
The idea behind Prolonged Exposure Therapy emerged from decades of research on how PTSD is maintained over time. As researchers gained a better understanding of the role avoidance plays in trauma, they began exploring what happens when people gradually approach, rather than avoid, trauma-related memories and situations (Steenkamp et al., 2015).
In Prolonged Exposure Therapy, individuals work with a trusted therapist to approach trauma-related memories and situations in a structured and gradual manner. This does not mean being thrown into the most distressing experience immediately. The process is collaborative and intentional. Over time, people begin gathering new information about situations, memories, and emotions that previously felt overwhelming.
One reason PE can seem intimidating is that it asks people to move toward discomfort rather than away from it. Yet decades of research have consistently found meaningful reductions in PTSD symptoms among individuals who complete treatment (Schnurr et al., 2022). Many people discover that situations they spent years avoiding become far more manageable than they expected.
Cognitive Processing Therapy (CPT)
While Prolonged Exposure Therapy focuses heavily on experience, Cognitive Processing Therapy places greater emphasis on meaning.
Traumatic experiences often leave people with difficult questions. Why did this happen? Could I have prevented it? Can I trust other people? Am I safe? These questions are understandable, and the conclusions people reach often make sense within the context of what they experienced. The difficulty arises when those conclusions become generalized beyond the circumstances that created them.
Someone who was betrayed by one person may begin expecting betrayal from everyone. Someone who experienced abuse may assume they are responsible for what happened. Someone who survived a random act of violence may begin viewing the world as entirely unsafe.
CPT helps people examine these beliefs and determine whether they continue to fit the evidence available today. The goal is not positive thinking or forced optimism. Instead, the process encourages people to evaluate whether trauma has shaped conclusions that no longer serve them (Steenkamp et al., 2015).
For many individuals, this work can feel surprisingly powerful. Sometimes the trauma itself is not the only source of suffering. The beliefs that formed afterward can continue creating distress long after the event has ended (Schnurr et al., 2022; Maguen et al., 2023).
Eye Movement Desensitization and Reprocessing (EMDR)
EMDR is perhaps one of the most recognizable trauma therapies, partly because it tends to generate curiosity. Many people first hear about it through friends, social media, podcasts, or personal recommendations.
During EMDR, individuals focus on aspects of a traumatic memory while engaging in bilateral stimulation, often through guided eye movements, tapping, or alternating sounds. Researchers continue debating exactly which components of the treatment account for its effectiveness (Steenkamp et al., 2015). What remains less controversial is the fact that EMDR has accumulated a substantial evidence base. Large studies have found meaningful improvements in PTSD symptoms, and major treatment guidelines consistently include EMDR among recommended first-line interventions (Schnurr et al., 2024; Zoellner et al., 2025).
One reason people are often drawn to EMDR is that it can feel different from traditional talk therapy. Some individuals who struggle to verbally process traumatic experiences find the structure particularly appealing. Others simply appreciate having multiple evidence-based options available.
Written Exposure Therapy (WET)
Written Exposure Therapy is one of the newer additions to the list of evidence-based PTSD treatments. It was developed, in part, to address a practical challenge: effective therapies are only helpful if people can access and complete them (Sloan et al., 2023).
Unlike many trauma-focused therapies, WET consists of just five sessions. During treatment, individuals write about their traumatic experience in a structured and intentional way. At first glance, the approach may seem surprisingly simple. Yet studies suggest that it can produce meaningful symptom improvement while maintaining lower dropout rates than some longer treatment formats (Sloan et al., 2018).
This does not mean WET is the best choice for everyone. It does, however, highlight an important reality in trauma treatment. Effective care does not always have to be lengthy or complicated. Sometimes relatively focused interventions can produce significant change.
PTSD Medication: Where It Fits In
Therapy receives much of the attention in discussions about PTSD, and for good reason. Current treatment guidelines generally recommend trauma-focused psychotherapy as the preferred first-line treatment when it is available and accessible (Schnurr et al., 2024; Zoellner et al., 2025; Rothbaum & Watkins, 2025). That does not mean medication lacks value.
Many people seek treatment while balancing work, parenting, caregiving responsibilities, financial stress, chronic health conditions, or limited access to specialized therapists. Others experience symptoms severe enough that they need additional support before therapy feels manageable. Medication management can play an important role in these situations.
One common misconception is that medication treats PTSD by helping people forget. In reality, the medications with the strongest evidence do not erase memories or remove the significance of what happened. Instead, they influence some of the biological systems involved in mood regulation, anxiety, threat perception, and emotional processing (Zoellner et al., 2025).
At present, sertraline (Zoloft) and paroxetine (Paxil) are the only medications approved by the FDA specifically for PTSD (Zoellner et al., 2025). Both belong to a class known as selective serotonin reuptake inhibitors, or SSRIs. Venlafaxine (Effexor), which belongs to a closely related class called serotonin-norepinephrine reuptake inhibitors, has also demonstrated strong evidence and is commonly recommended in treatment guidelines (Schnurr et al., 2024).
One challenge with PTSD medications is that improvement tends to occur gradually. People often hope for a dramatic change, particularly when symptoms have been present for years. More commonly, benefits emerge over several weeks and appear in stages. Sleep may improve before anxiety. Irritability may decrease before concentration improves. Some symptoms respond more quickly than others.
For many individuals, medication works best when viewed as one component of a broader treatment plan rather than a standalone solution.
When Sleep and Nightmares Become the Main Problem
When people with PTSD are asked which symptom affects their daily life the most, sleep frequently appears near the top of the list.
Poor sleep affects concentration, mood, memory, emotional regulation, and overall quality of life. When sleep becomes disrupted, many other symptoms become more difficult to manage.
Nightmares deserve particular attention because they can create a frustrating cycle. A person begins dreading sleep because sleep has become associated with distress. The resulting sleep deprivation then amplifies anxiety, irritability, and hypervigilance during the day.
One medication that has received considerable attention for trauma-related nightmares is prazosin (Minipress). Originally developed as a blood pressure medication, prazosin appears to reduce nightmares for some individuals by affecting parts of the body’s stress response system. Research findings have been mixed, but many people find it very helpful when nightmares are a prominent concern (Raskind et al., 2018; Zhang et al., 2022).
Another approach, known as Imagery Rehearsal Therapy, takes a different path. Rather than relying on medication, individuals intentionally rewrite recurring nightmares while awake and mentally rehearse alternative versions. The idea can sound unusual at first, yet studies suggest it can meaningfully reduce nightmare frequency and severity for some people (Zhang et al., 2022; Morgenthaler et al., 2018).
Regardless of the approach, addressing sleep often creates benefits that extend well beyond nighttime symptoms.
Treatments That Deserve a More Careful Conversation
The internet has made information about PTSD more accessible than ever. That accessibility has helped many people recognize symptoms, learn about treatment options, and seek support they might not have otherwise found. At the same time, it has made it easier for misinformation, oversimplified claims, and treatments that outpace the evidence to spread widely.
Benzodiazepines, including medications such as alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium), can reduce anxiety in the short term. That immediate relief understandably makes them appealing. The problem is that decades of research have failed to demonstrate meaningful benefits for the core symptoms of PTSD. Some studies have even suggested they may interfere with aspects of trauma recovery (Campos et al., 2022). For this reason, most major treatment guidelines recommend against using benzodiazepines as a primary treatment for PTSD.
Cannabis is frequently discussed as a potential treatment for PTSD, but the current evidence does not support it as a first-line intervention. While some individuals report short-term symptom relief, research findings have been inconsistent, and cannabis may worsen anxiety, affect concentration and memory, or contribute to dependence in some people (Kansagara et al., 2026; Rodas et al., 2024). As a result, major treatment guidelines generally recommend evidence-based therapies and medications with stronger research support when treating PTSD (Schnurr et al., 2024).
Psychedelic-assisted therapies, including research involving MDMA and psilocybin, have received significant media attention in recent years. While some studies have reported encouraging results, these treatments remain investigational and are not currently considered first-line treatments for PTSD. Importantly, the research has taken place in highly structured clinical settings that involve extensive screening, preparation, monitoring, and therapeutic support (Reiff et al., 2020). These conditions differ substantially from recreational or unsupervised use. Questions regarding long-term outcomes, safety, accessibility, and implementation remain under investigation, and additional research is needed before these approaches can be considered part of routine PTSD care (Schnurr et al., 2024; Wolfgang et al., 2025).
What Recovery Usually Looks Like
One challenge in writing about PTSD treatment is that recovery often looks different than people expect. Many people imagine improvement as a dramatic event. Symptoms disappear. Anxiety vanishes. Life returns to exactly what it was before the trauma occurred. Research and clinical experience suggest something more gradual.
A person notices they can drive a route they previously avoided. A crowded store feels manageable again. A difficult memory still appears, but it no longer consumes the rest of the day. Sleep becomes more predictable. Relationships require less effort to maintain. These changes rarely happen all at once. More often, they accumulate quietly over time.
One of the most consistent findings in trauma research is that the brain remains capable of learning long after trauma occurs. Experiences shape us, but they do not permanently determine how we respond to the future (Rothbaum & Watkins, 2025). Much of modern PTSD treatment is built around that idea. Different therapies approach it from different angles. Medications may support it in different ways. The details vary, but the underlying principle remains remarkably consistent: what was learned in the context of danger can be relearned in the context of safety.
Taking the First Step
Trauma can shape the way people see themselves, other people, and the world around them. It can influence expectations, relationships, and daily routines in ways that are easy to overlook while they are happening. Yet one of the most encouraging lessons to emerge from trauma research is that these patterns are not fixed. The brain is constantly learning from experience. The same brain that learned to anticipate danger, disappointment, rejection, or harm can also learn that safety exists, that trust can be rebuilt, that the other shoe does not always have to drop, and that not every future experience will resemble the past.
This does not mean forgetting what happened or pretending it no longer matters. Some experiences leave lasting marks, and recovery is rarely about erasing them. More often, it involves allowing new experiences to gradually carry as much weight as the old ones. A safe relationship. A good night’s sleep. A difficult conversation that ends differently than expected. A moment of peace that lasts a little longer than it used to. Over time, those experiences can begin updating expectations that were formed under very different circumstances.
If this article has resonated with you, I hope it has helped make sense of some experiences that may have felt confusing, frustrating, or difficult to put into words. Sometimes one of the most meaningful shifts is not learning something entirely new, but finally having a framework for experiences that never quite made sense before. And if some of your experiences feel a little more understandable after reading this, then that’s a good place to start. When you’re ready to seek support, please know there are evidence-based, trauma-informed mental health professionals who can help you navigate what comes next.
Quick answers
In short: Current guidelines generally recommend trauma-focused psychotherapy, such as Prolonged Exposure or Cognitive Processing Therapy, as the preferred first-line treatment for PTSD when it is available. Medication can also play an important role, for example when therapy is hard to access or symptoms are severe.
What are the symptoms of PTSD?
Clinicians group PTSD symptoms into four categories: intrusive symptoms such as flashbacks, nightmares, and unwanted memories; avoidance of reminders; changes in mood and thinking, such as numbness, guilt, or shame; and changes in arousal and reactivity, such as poor sleep, difficulty concentrating, being easily startled, and irritability. Two people with PTSD can have very different experiences of it.
What therapies are recommended for PTSD?
Current guidelines generally recommend trauma-focused psychotherapy as the preferred first-line treatment for PTSD when it is available. Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT) are recommended by major guidelines, and the VA/DoD guideline also recommends EMDR. Written Exposure Therapy (WET) is a newer, five-session option; studies suggest it can reduce symptoms with fewer dropouts than some longer therapies. Different people respond to different approaches.
How do Prolonged Exposure, CPT, EMDR, and Written Exposure Therapy differ?
Each takes a different route to the same goal. Prolonged Exposure helps people gradually approach trauma-related memories and situations with a therapist. Cognitive Processing Therapy focuses on meaning, examining beliefs formed after trauma. EMDR pairs focus on a traumatic memory with bilateral stimulation, such as guided eye movements. Written Exposure Therapy involves structured writing about the trauma over five sessions.
What medications are used to treat PTSD?
Sertraline (Zoloft) and paroxetine (Paxil), both SSRIs, are currently the only medications approved by the FDA specifically for PTSD. Venlafaxine (Effexor), a closely related SNRI, is also recommended in the VA/DoD treatment guideline. Guidelines generally prefer trauma-focused therapy as the first-line treatment when it is available, but medication can play an important role, for example when therapy is hard to access or symptoms are severe.
Are benzodiazepines or cannabis recommended for PTSD?
Generally, no. Most major guidelines recommend against using benzodiazepines, such as Xanax or Valium, to treat PTSD, because research has not shown meaningful benefits for its core symptoms. Current evidence does not support cannabis as a first-line PTSD treatment: research findings have been inconsistent, and cannabis may contribute to dependence in some people. Guidelines instead favor therapies and medications with stronger research support.
What helps with PTSD nightmares?
Two approaches studied for trauma-related nightmares are the medication prazosin and Imagery Rehearsal Therapy (IRT). Prazosin appears to reduce nightmares for some people, but research findings have been mixed. In IRT, a person rewrites a recurring nightmare while awake and mentally rehearses the new version; studies suggest this can meaningfully reduce nightmare frequency and severity for some people.
Ready to schedule an appointment?
Contact Peak Mental Healthcare today to book your first appointment. We’re here to help you take the next step toward feeling like yourself again.
This article is for general education and isn't a substitute for personal medical advice.
References
Campos, B., Vinder, V., Passos, R. B. F., Berger, W., Coutinho, E. S. F., Mendlowicz, M. V., Figueira, I., & Volchan, E. (2022). To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis. Journal of Psychopharmacology, 36(4), 449–459. https://doi.org/10.1177/02698811221080464
Kansagara, D., Terry, G. E., Ayers, C. K., & D’Souza, D. C. (2026). Cannabis and mental health: A review. JAMA Internal Medicine. Advance online publication. https://doi.org/10.1001/jamainternmed.2025.8215
Maguen, S., Madden, E., Holder, N., Li, Y., Seal, K. H., Neylan, T. C., Lujan, C., Patterson, O. V., DuVall, S. L., & Shiner, B. (2023). Effectiveness and comparative effectiveness of evidence-based psychotherapies for posttraumatic stress disorder in clinical practice. Psychological Medicine, 53(2), 419–428. https://doi.org/10.1017/S0033291721001628
Morgenthaler, T. I., Auerbach, S., Casey, K. R., Kristo, D., Maganti, R., Ramar, K., Zak, R., & Kartje, R. (2018). Position paper for the treatment of nightmare disorder in adults: An American Academy of Sleep Medicine position paper. Journal of Clinical Sleep Medicine, 14(6), 1041–1055. https://doi.org/10.5664/jcsm.7178
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., Romesser, J., Rosenheck, R., Shih, M.-C., Stein, M. B., Swift, R., Gleason, T., Lu, Y., & Huang, G. D. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. The New England Journal of Medicine, 378(6), 507–517. https://doi.org/10.1056/NEJMoa1507598
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., & McDonald, W. M. (2020). Psychedelics and psychedelic-assisted psychotherapy. The American Journal of Psychiatry, 177(5), 391–410. https://doi.org/10.1176/appi.ajp.2019.19010035
Rodas, J. D., George, T. P., & Hassan, A. N. (2024). A systematic review of the clinical effects of cannabis and cannabinoids in posttraumatic stress disorder symptoms and symptom clusters. The Journal of Clinical Psychiatry, 85(1), 23r14862. https://doi.org/10.4088/JCP.23r14862
Rothbaum, B. O., & Watkins, L. E. (2025). An update on psychotherapy for the treatment of PTSD. The American Journal of Psychiatry, 182(5), 424–437. https://doi.org/10.1176/appi.ajp.20250110
Sartor, Z., Kelley, L., & Laschober, R. (2023). Posttraumatic stress disorder: Evaluation and treatment. American Family Physician, 107(3), 273–281.
Schnurr, P. P., Chard, K. M., Ruzek, J. I., Forber-Pratt, A. J., Friedman, M. J., Killeen, T. K., Miele, G. M., Norman, S. B., Rauch, S. A. M., Schnurr, P. P., & Shih, M.-C. (2022). Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: A randomized clinical trial. JAMA Network Open, 5(1), e2136921. https://doi.org/10.1001/jamanetworkopen.2021.36921
Schnurr, P. P., Hamblen, J. L., Wolf, J., Coller, R., Colpe, L., Fullerton, C. S., Grubaugh, A. L., Klap, R., Korte, K. J., Lu, S. E., Morganstein, J. C., Norman, S. B., Rosen, C., Ruzek, J. I., Shea, M. T., Sripada, R. K., Stein, D. J., & Ursano, R. J. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Annals of Internal Medicine, 177(3), 363–374. https://doi.org/10.7326/M23-2757




